期刊
NANO TODAY
卷 18, 期 -, 页码 65-85出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2017.12.007
关键词
Nanomedicine; Dual-ligand; Tumor-targeted delivery; Tumor therapy; Receptor-mediated endocytosis; Cell-penetrating peptides; Targeting efficacy
资金
- National Natural Science Foundation of China [NSFC 51633005]
Based on the overexpression of specific receptors on tumor cells, active targeting nanomedicines have been developed with the ability to efficiently deliver imaging agents in the tumor area or anticancer drugs into tumor cells via receptor-mediated endocytosis. Nevertheless, the efficacy of single-ligand nanomedicines is still limited due to the complexity of the tumor microenvironment. In recent years, dual-ligand nanomedicines have attracted a lot of interest, because these nanomedicines endowed with versatile functions, have the potential to improve the efficacy of tumor-targeted delivery. In this review, an overview of various dual-ligand nanomedicines for tumor targeted therapy will be presented, the role of cell penetrating peptides in combination with targeting ligands will be discussed and factors that affect the targeting efficacy of dual-ligand nanomedicines will be evaluated. (C) 2017 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据